Literature DB >> 34643913

In Vitro Assessment of Drug Activity Against Mycobacterium ulcerans.

Oliver D Komm1, Deepak V Almeida2, Paul J Converse1, Eric L Nuermberger1.   

Abstract

As acknowledged by the Clinical and Laboratory Standards Institute (CLSI), there is an insufficient evidence base on which to recommend a standard method for antimicrobial susceptibility testing against M. ulcerans. The agar proportion method has been recognized as the standard method for susceptibility testing against Mycobacterium tuberculosis complex (MTBC) isolates for decades (Woods GL, Engenack NL, Lin G, Turnidge JD (2018) CLSI standards: guidelines for health care excellence. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic Actinomycetes, 3rd edn. Clinical and Laboratory Standards Institute Copyright©2018 Clinical and Laboratory Standards Institute, Wayne (PA)). While it is more labor-intensive and requires larger amounts of drug or compound than broth-based testing, we recommend the agar proportion method for determination of minimum inhibitory concentrations against M. ulcerans. Herewith we present the method we implemented in our laboratory over the last 2 decades.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Agar proportion method; Buruli ulcer; In vitro susceptibility testing; Minimal inhibitory concentration (MIC); Mycobacterium ulcerans

Mesh:

Substances:

Year:  2022        PMID: 34643913      PMCID: PMC8996815          DOI: 10.1007/978-1-0716-1779-3_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.

Authors:  Tianyu Zhang; William R Bishai; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

Review 2.  Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans.

Authors:  Achille Yemoa; Joachim Gbenou; Dissou Affolabi; Mansourou Moudachirou; André Bigot; Séverin Anagonou; Françoise Portaels; Joëlle Quetin-Leclercq; Anandi Martin
Journal:  Planta Med       Date:  2011-01-14       Impact factor: 3.352

3.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

4.  Survival of Mycobacterium ulcerans at 37 degrees C.

Authors:  M Eddyani; F Portaels
Journal:  Clin Microbiol Infect       Date:  2007-08-13       Impact factor: 8.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.